Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.45 |
| ▸ | CCR2 | P41597 | 15/20 | 0.44 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.43 |
| ▸ | CSF1R | P07333 | 1/20 | 0.43 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.43 |
| ▸ | KIT | P10721 | 1/20 | 0.43 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.43 |
| ▸ | RAF1 | P04049 | 1/20 | 0.42 |
| ▸ | BRAF | P15056 | 1/20 | 0.42 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL631768 | 0.90 | CCR2 (0.45) | CCR2KCNH2 | |
| SCHEMBL632419 | 0.86 | CCR2 (0.47) | CCR2KCNH2 | |
| SCHEMBL632814 | 0.85 | CCR2 (0.47) | CCR2KCNH2 | |
| SCHEMBL629389 | 0.85 | CCR2 (0.47) | CCR2KCNH2 | |
| SCHEMBL632445 | 0.84 | CCR2 (0.50) | CCR2KCNH2 | |
| SCHEMBL631721 | 0.83 | CCR2 (0.46) | CCR2KCNH2 | |
| SCHEMBL633221 | 0.83 | CCR2 (0.46) | CCR2KCNH2CSF1RPDGFRBKIT | |
| SCHEMBL632403 | 0.82 | CCR2 (0.43) | CCR2KCNH2RAF1BRAF | |
| SCHEMBL629038 | 0.81 | CCR2 (0.52) | CCR2KCNH2 | |
| SCHEMBL629391 | 0.81 | CCR2 (0.48) | CCR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2419418-A1 | 4-AZETIDINYL-1-HETEROATOM LINKED-CYCLOHEXANE ANTAGONISTS OF CCR2 | Janssen Pharmaceutica, N.V. (BE) | 2012-02-22 | — | — | EP | disclosed |
| WO-2010121036-A1 | 4-AZETIDINYL-1-HETEROATOM LINKED-CYCLOHEXANE ANTAGONISTS OF CCR2 | JANSSEN PHARMACEUTICA NV (BE) | 2010-10-21 | — | — | WO | disclosed |